ReviewJournal of psychopharmacology (Oxford, England)2026
Learning as the unifying mechanism of psychedelic action.
Review in Journal of psychopharmacology (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Psilocybin selectively rescues cognitive flexibility impairments caused by aberrant prefrontal error signaling.bioRxiv : the preprint server for biology · 2026Article
- Systems-based psychiatry: insights from psychedelic research on mechanisms of healing.Frontiers in psychiatry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Psychedelics are gaining attention as putative treatments for a range of psychiatric conditions, and evidence suggests that they produce sustained behavioural and clinical change. Enhanced learning is an emerging candidate mechanism mediating these sustained effects. This narrative review synthesises evidence across behavioural, neural and computational levels to examine the current evidence base for how psychedelics may alter learning mechanisms. We propose that viewing psychedelic mechanisms through the lens of learning unifies context-dependent outcomes, increased environmental sensitivity and neuroplastic change. We discuss how persistent changes in top-down and bottom-up information processing at a systems-level may account for both the therapeutic and adverse effects of psychedelics, and highlight a mechanistic convergence between such systems-level changes and the recently identified psychedelic-mediated reopening of critical learning periods. This systems-level framework may explain why psychedelic outcomes vary widely and hinge critically on the context: it is the learning environment, including psychological support and therapeutic insights, which shapes the lasting effect. If the post-psychedelic period is characterised by a vulnerable neuroplastic state in combination with increased environmental sensitivity, usually observed uniquely during childhood, this would offer a window of opportunity for revision of entrenched beliefs. Understanding these mechanisms has important translational relevance for the design and implementation of psychedelic-assisted psychotherapy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.